Adicet Bio (ACET) Cash & Equivalents (2017 - 2026)
Adicet Bio (ACET) reported Cash & Equivalents of $33.13 million for Q2 2026, down 4.6% from $34.72 million a year earlier and down 8.6% from the prior quarter.
Adicet Bio (ACET) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Adicet Bio posted Cash & Equivalents of $38.92 million, down 31.1% from FY2024.
- Cash & Equivalents has declined for four consecutive years, with a five-year compound annual growth rate of -14.3% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $56.5 million in FY2024 (-64.6%), $159.71 million in FY2023 (-38.0%), $257.66 million in FY2022 (-7.2%) and $277.54 million in FY2021 (+229.1%).
- Five-year quarterly Cash & Equivalents spans a low of $28.13 million in Q1 2025 and a high of $282.68 million in Q3 2022.
- Year over year, Cash & Equivalents gained in 1 of the last eight quarters, with an average decline of 44.2%.
- The high point for year-over-year Cash & Equivalents in five years was Q4 2021 (growth of 229.1%); the low point was Q2 2025 (a decline of 84.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $36.25 million (Q1 2026), $38.92 million (Q4 2025) and $29.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Adicet Bio | 37.35 Mn | -480.06 Mn | - | 33.13 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.13 Mn |
| Mar 31, 2026 | 36.25 Mn |
| Dec 31, 2025 | 38.92 Mn |
| Sep 30, 2025 | 29.10 Mn |
| Jun 30, 2025 | 34.72 Mn |
| Mar 31, 2025 | 28.13 Mn |
| Dec 31, 2024 | 56.50 Mn |
| Sep 30, 2024 | 105.48 Mn |
| Jun 30, 2024 | 224.07 Mn |
| Mar 31, 2024 | 159.71 Mn |
| Dec 31, 2023 | 159.71 Mn |
| Sep 30, 2023 | 183.26 Mn |
| Jun 30, 2023 | 205.46 Mn |
| Mar 31, 2023 | 231.64 Mn |
| Dec 31, 2022 | 257.66 Mn |
| Sep 30, 2022 | 282.68 Mn |
| Jun 30, 2022 | 260.64 Mn |
| Mar 31, 2022 | 277.88 Mn |
| Dec 31, 2021 | 277.54 Mn |
| Sep 30, 2021 | 192.23 Mn |
Adicet Bio Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ACET&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ACET", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ACET&period=max&api_key=YOUR_API_KEY");
const data = await res.json();